New

Global ETF Survey 2026: Answer now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Take the survey

›ETF Issuers›Mirae Asset Global Investments›227540

227540

Mirae Asset TIGER 200 HEALTH CARE ETF

Passive ETF Equity

Not rated

The 227540 Exchange Traded Fund (ETF) is provided by Mirae Asset Global Investments. It is built to track an index: KOSPI 200 Health Care Sector Index. The 227540 ETF provides physical exposure, so by buying it you actually own parts of all the 14 underlying holdings. This share class generates a stream of income by distributing dividends.

₩17,755

-₩180 (-1.00%) today

12:00 AM 08/03/26 Closed

1D price range

₩17,420₩18,030

52W price range

₩16,938.44₩25,621.32

YTD Perf.

-20.75%

YTD Flows

Annualized volatility

Fund AuM

€18M

Share class AuM

€18M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

KR7227540002

TER

0.4%

Inception date

9/23/2015

Issuer

Mirae Asset Global Investments

Benchmark

KOSPI 200 Health Care Sector Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
364970 Mirae Asset TIGER BIO TOP10 ETF	+1.10%
139280 Tiger Consumer Staples ETF	-2.40%

API

PerformanceDec 30, 2025 - Jul 31, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Healthcare

99.76%

Unavailable

0.24%

Latest 227540 news

No content available for this fund

FAQ about 227540

227540 is a Passive ETF. This ETF provides exposure to Large Cap South Korean Health Care Equities.

227540 tracks the KOSPI 200 Health Care Sector Index - KRW, through a full replication replication method.

227540 carries a total expense ratio (TER) of 0.4%, indicating the annual cost for holding the fund.

227540 was introduced to the market on September 23, 2015. It trades on Moldova, Republic of, among other exchanges

Mirae Asset TIGER 200 HEALTH CARE ETF, 227540, is provided by Mirae Asset Global Investments. Learn more about Mirae Asset Global Investments here.

227540 oversees €18M in assets as of July 31, 2026.

227540 follows a distributing dividend policy, meaning it pays out income to investors. As of July 31, 2026, its 12-month trailing yield was 0.50%.

As of June 30, 2026, 227540 has significant geographic allocations in Republic of Korea.

As of June 30, 2026, 227540 focuses largely on Healthcare.

As of June 30, 2026, 227540 holds 14 positions in its portfolio, with 99.76% of assets concentrated in its top 15 holdings.

As of June 30, 2026, 227540 top three holdings include SAMSUNG BIOLOGICS Co., Ltd., Celltrion, Inc. and Yuhan Corp..

The base currency of 227540 is KRW.

Top 10 holdings

Data as of 06/30/26

SAMSUNG BIOLOGICS Co., Ltd.

21.40%

Celltrion, Inc.

19.76%

Yuhan Corp.

13.17%

SK Biopharmaceuticals Co., Ltd.

10.63%

Hanmi Pharmaceutical Co., Ltd.

7.86%

Samsung Epis Holdings Co., Ltd.

7.44%

HANALL BIOPHARMA Co., Ltd.

6.96%

SK bioscience Co., Ltd.

2.91%

Hanmi Science Co., Ltd.

2.65%

GC Biopharma Corp.

2.01%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The ETF Industry Is Evolving Fast

Mirae Asset TIGER 200 HEALTH CARE ETF

FAQ about 227540

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US